FRMD4A/RET: A Novel RET Oncogenic Fusion Variant in Non-Small Cell Lung Carcinoma

J Thorac Oncol. 2017 Feb;12(2):e15-e16. doi: 10.1016/j.jtho.2016.11.274.

Authors

Vamsidhar Velcheti¹, Rajat Thawani², Monica Khunger³, Sanjay Mukhopadhyay⁴, Deborah J Chute⁴, Alexa B Schrock⁵, Siraj M Ali⁵

Affiliations

¹ Department of Hematology and Oncology Cleveland Clinic, Cleveland, Ohio. Electronic address: velchev@ccf.org.
² Department of Oncology Case Western, Reserve University, Cleveland, Ohio.
³ Department of Internal Medicine Cleveland Clinic, Cleveland, Ohio.
⁴ Department of Pathology Cleveland Clinic, Cleveland, Ohio.
⁵ Foundation Medicine, Boston, Massachusetts.

PMID: 28115111
DOI: 10.1016/j.jtho.2016.11.274

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Carcinoma, Non-Small-Cell Lung / genetics*
Carcinoma, Non-Small-Cell Lung / pathology
Female
Humans
Lung Neoplasms / genetics*
Lung Neoplasms / pathology
Oncogene Fusion / genetics*
Proto-Oncogene Proteins c-ret / genetics*

Substances

Proto-Oncogene Proteins c-ret